Solid focal liver lesions: Dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine

Journal of Gastrointestinal Cancer

Volumn 41, Issue 4, 2010, Pages 221-232

  Grazioli, Luigi ^a   Bondioni, Maria Pia ^a   Faccioli, Niccolò ^b   Gambarini, Sebastiana ^a   Tinti, Rita ^a   Schneider, Günther ^c   Kirchin, Miles ^d  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c SAARLAND UNIVERSITY   (Germany)

^d Bracco Medical Department   (Italy)

Author keywords

contrast media; liver; magnetic resonance imaging; meglumine

Indexed keywords

GADOBENATE DIMEGLUMINE;

ARTICLE; CONTRAST ENHANCEMENT; HUMAN; IMAGE ANALYSIS; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

EID: 78649474092     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9145-0     Document Type: Article

References (46)

1. A Spinazzi V Lorusso G Pirovano P Taroni M Kirchin A Davies 1998 MultiHance clinical pharmacology: biodistribution and MR enhancement of the liver Acad Radiol 5 S86 9 10.1016/S1076-6332(98)80069-X 9561052
2. MA Kirchin G Pirovano A Spinazzi 1998 Gadobenate dimeglumine (Gd-BOPTA): an overview Invest Radiol 33 798 809 1:CAS:528:DyaK1cXnsFGrsbk%3D 10.1097/00004424-199811000-00003 9818314 (Pubitemid 30247065)
3. A Spinazzi V Lorusso G Pirovano M Kirchin 1999 Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine Acad Radiol 6 282 91 1:STN:280:DyaK1M3ksFejsw%3D%3D 10.1016/S1076-6332(99)80451-6 10228617
4. FM Cavagna F Maggioni PM Castelli, et al. 1997 Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging Invest Radiol 32 780 96 1:CAS:528:DyaK2sXnvFGhur4%3D 10.1097/00004424-199712000-00009 9406019 (Pubitemid 28053510)
5. FL Giesel H von Tengg-Kobligk ID Wilkinson P Siegler CW von Der Lieth M Frank KP Lodemann M Essig 2006 Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 and R2) of magnetic resonance contrast agents Invest Radiol 41 222 8 1:CAS:528:DC%2BD28XhsVKqtrw%3D 10.1097/01.rli.0000192421.81037.d5 16481904 (Pubitemid 44406182)
6. C de Haën M Cabrini L Akhnana D Ratti L Calabi L Gozzini 1999 Gadobenate dimeglumine 0.5M solution for injection (MultiHance®): pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium J Comput Assist Tomogr 23 Suppl. 1 S161 8 10608412
7. J Pintaske P Martirosian H Graf G Erb KP Lodemann CD Claussen F Schick 2006 Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla Invest Radiol 41 213 21 10.1097/01.rli.0000197668.44926.f7 16481903 Erratum Invest Radiol 2006; 41:859 (Pubitemid 44406181)
8. G Schneider R Maas L Schultze Kool E Rummeny HB Gehl K Lodemann MA Kirchin 2003 Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison Invest Radiol 38 85 94 1:CAS:528:DC%2BD3sXlsFKjsg%3D%3D 10.1097/00004424-200302000-00003 12544071 (Pubitemid 36125892)
9. R Kuwatsuru M Kadoya K Ohtomo, et al. 2001 Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for MR imaging of liver tumors Invest Radiol 36 632 41 1:CAS:528:DC%2BD3MXovVGit7g%3D 10.1097/00004424-200111000- 00002 11606840 (Pubitemid 33021091)
10. R Caudana G Morana G Pirovano, et al. 1996 Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA) - preliminary results of phase II clinical application Radiology 199 513 20 1:CAS:528:DyaK28XivFamsL8%3D 8668804
11. J Petersein A Spinazzi A Giovagnoni, et al. 2000 Evaluation of the efficacy of gadobenate dimeglumine in MR imaging of focal liver lesions: a multicenter phase III clinical study Radiology 215 727 36 1:STN:280: DC%2BD3c3ptlCgug%3D%3D 10831691
12. G Pirovano A Vanzulli L Marti-Bonmati, et al. 2000 Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions AJR Am J Roentgenol 175 1111 20 1:STN:280:DC%2BD3cvpvVyrug%3D%3D 11000175
13. L Grazioli G Morana R Caudana, et al. 2000 Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings Invest Radiol 35 25 34 1:STN:280:DC%2BD3c7gt1Gksw%3D%3D 10.1097/00004424- 200001000-00003 10639033 (Pubitemid 30033604)
14. L Grazioli G Morana MP Federle, et al. 2001 Focal nodular hyperplasia: morphological and functional information from MR imaging with gadobenate dimeglumine Radiology 221 731 9 1:STN:280:DC%2BD3MnntlOqtA%3D%3D 10.1148/radiol.2213010139 11719669
15. L Grazioli G Morana MA Kirchin, et al. 2003 MR Imaging of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (Ferumoxides): an intra-individual comparison J Magn Reson Imaging 17 593 602 10.1002/jmri.10289 12720270 (Pubitemid 36528676)
16. YK Kim JM Lee CS Kim 2004 Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions Eur Radiol 14 5 13 10.1007/s00330-003-2115-1 14600778 (Pubitemid 38181049)
17. YK Kim CS Kim YH Lee HS Kwak JM Lee 2004 Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas AJR Am J Roentgenol 182 1217 23 15100122
18. YK Kim JM Lee CS Kim GH Chung CY Kim IH Kim 2005 Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging Eur Radiol 15 220 8 10.1007/s00330-004-2570-3 15624108
19. L Grazioli G Morana MA Kirchin G Schneider 2005 Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study Radiology 236 166 77 10.1148/radiol.2361040338 15955857 (Pubitemid 40853309)
20. I Wanless C Mawdsley R Adams, et al. 1985 On the pathogenesis of focal nodular hyperplasia of the liver Hepatology 5 1194 200 1:STN:280: DyaL28%2FlslCgtQ%3D%3D 10.1002/hep.1840050622 4065824 (Pubitemid 16222291)
21. D Cherqui A Rahmouni F Charlotte, et al. 1995 Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations Hepatology 22 1674 81 1:STN:280:DyaK28%2FovVyhsw%3D%3D 10.1002/hep.1840220610 7489973
22. P Labrune P Trioche I Duvaltier P Chevalier M Odièvre 1997 Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature J Pediatr Gastroenterol Nutr 24 276 9 1:CAS:528:DyaK2sXjt1artLw%3D 10.1097/00005176-199703000-00008 9138172 Review (Pubitemid 27199615)
23. T Leese O Farges H Bismuth 1988 Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit Ann Surg 208 558 64 1:STN:280:DyaL1M%2FkvFalsw%3D%3D 10.1097/00000658-198811000-00003 3190282
24. Molina EG, Schiff ER. Benign solid lesion of the liver, chapter 53. In: Schiff's. Diseases of the liver (8th edition) Vol.II. Lippincott-Raven 1999,53, page 1254-1257.
25. L Arrive JF Flejou V Vilgrain, et al. 1994 Hepatic adenoma: MR findings in 51 pathologically proved lesions Radiology 193 507 12 1:STN:280: DyaK2M%2Fmt12qtA%3D%3D 7972769
26. IR Wanless 1990 Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules Hepatology 11 787 97 1:STN:280:DyaK3c3mvFOmtw%3D%3D 10.1002/hep.1840110512 2189821 Review (Pubitemid 20191384)
27. IR Wanless 1996 Noncirrhotic portal hypertension: recent concepts Prog Liver Dis 14 265 78 1:CAS:528:DyaK2sXhvVeltLo%3D 9055582
28. M Arvanitaki M Adler 2001 Nodular regenerative hyperplasia of the liver. A review of 14 cases Hepatogastroenterology 48 1425 9 1:STN:280: DC%2BD3MrntFansA%3D%3D 11677979
29. G Brancatelli MP Federle L Grazioli, et al. 2002 Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinico-pathologic correlation AJR Am J Roentgenol 178 877 83 11906867
30. J Bruix M Sherman JM Llovet, et al. 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 30 1:STN:280:DC%2BD3MrksFCmtg%3D%3D 10.1016/S0168-8278(01)00130-1 11592607 (Pubitemid 32844200)
31. M Sakamoto S Hirohashi Y Shimosato 1991 Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma Human Pathol 22 172 8 1:STN:280:DyaK3M7mtFWmsg%3D%3D 10.1016/0046-8177(91) 90039-R
32. BI Choi K Takayasu MC Han 1993 Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings AJR Am J Roentgenol 160 1177 87 1:STN:280:DyaK3s3mvFKrsg%3D%3D 8388618
33. S Noguchi R Yamamoto M Tatsuta, et al. 1986 Cell features and patterns in fine-needle aspirates of hepatocellular carcinoma Cancer 58 321 8 1:STN:280:DyaL283ksVKmtg%3D%3D 10.1002/1097-0142(19860715)58:2<321::AID- CNCR2820580219>3.0.CO;2-B 3013389
34. R Manfredi G Maresca R Baron, et al. 1999 Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA) J Magn Reson Imaging 9 704 10 1:STN:280:DyaK1M3mtVKisg%3D%3D 10.1002/(SICI)1522- 2586(199905)9:5<704::AID-JMRI13>3.0.CO;2-Z 10331767 (Pubitemid 29211165)
35. Craig JR, Peters RL, Edmonson HA. Tumors of the liver and intrahepatic bile ducts: atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology; 1989.
36. Y Maetani K Itoh C Watanabe, et al. 2001 MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation AJR Am J Roentgenol 176 1499 507 1:STN:280:DC%2BD3M3ovF2lug%3D%3D 11373220
37. V Vilgrain BE Van Beers JF Flejou, et al. 1997 Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients J Comput Assist Tomogr 21 59 65 1:STN:280:DyaK2s7nsFWisw%3D%3D 10.1097/00004728- 199701000-00012 9022771 (Pubitemid 27061157)
38. T Murakami H Nakamura K Tsuda, et al. 1995 Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study J Magn Reson Imaging. 5 165 70 1:STN:280:DyaK2M3osVCmsA%3D%3D 10.1002/jmri.1880050210 7766977
39. Y Zhang M Uchida T Abe, et al. 1999 Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI J Comput Assist Tomogr 23 670 7 1:STN:280:DyaK1Mvlt1Cktg%3D%3D 10.1097/00004728-199909000-00004 10524843 (Pubitemid 29463798)
40. M Ohsawa K Aozasa K Horiuchi, et al. 1992 Malignant lymphoma of the liver Dig Dis Sci 37 1105 9 1:STN:280:DyaK38zhsFOrtQ%3D%3D 10.1007/BF01300294 1618060
41. ES Jaffe 1987 Malignant lymphoma: pathology of hepatic involvement Semin Liver Dis 7 257 68 1:STN:280:DyaL1c%2FntVOhsw%3D%3D 10.1055/s-2008-1040581 3317862
42. C Bartolozzi D Cioni F Donati, et al. 2001 Focal liver lesions: MR imaging-pathologic correlation Eur Radiol 11 1374 88 1:STN:280: DC%2BD3Mvns1aitw%3D%3D 10.1007/s003300100845 11519546 (Pubitemid 32755622)
43. Goodman ZD. Nonparenchymal and metastatic malignant tumors of the liver. In: Haubrich WS, Schaffner F, Berk JE, editors. Bockus Gastroenterology. Philadelphia: WB Saunders; 1995. p. 2488-500.
44. RE Larson RC Semelka AS Bagley PL Molina ED Brown JK Lee 1994 Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT Radiology 192 393 9 1:STN:280:DyaK2czgt1ahtg%3D%3D 8029403
45. JT Ferrucci 1994 Liver tumor imaging. Current concepts Radiol Clin North Am 32 39 54 1:STN:280:DyaK2c7ht1Wrsw%3D%3D 8284360
46. KH Lewis JL Chezmar 1997 Hepatic metastases Magn Reson Imaging Clin North Am 5 319 30 1:STN:280:DyaK2s3mvV2kug%3D%3D